PYRAZOLOPYRIDAZINDERIVATE

Patent europeic · EP1463730 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1463730
Numer da la dumonda
EP02805104
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
11-12-2002
Publitgà
06-10-2004
Concedì
19-04-2006
Stritgà
19-04-2006
Motiv
Nagin effect per la Svizra ed il Liechtenstein
Classas IPC
C07D 487/04 (2006.01)
A61K 31/5025 (2006.01)
A61P 35/00 (2006.01)
//C07D 487/04 (2006.01)
//C07D 237/00 (2006.01)
//C07D 231/00 (2006.01)
Prioritad
US 341798 P 17.12.2001
Dumonda PCT
PCT/US2002/039672 11.12.2002
Publicaziun PCT
WO2003/051886 26.06.2003
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 31-10-2006

    Midada

    Published in +pat+ No 20 in 2006

  2. 28-04-2006

    Concedì

    Published in +pat+ No 8 in 2006

Partidas

Inventur

HARRIS, Phillip Anthony, c/o GlaxoSmithKline

Research Triangle Park, NC 27709, US

JUNG, David Kendall, c/o GlaxoSmithKline

Research Triangle Park, NC 27709, US

PEEL, Michael Robert, c/o GlaxoSmithKline

Research Triangle Park, NC 27709, US

RENO, Michael John, c/o GlaxoSmithKline

Research Triangle Park, NC 27709, US

RHEAULT, Tara Renae, c/o GlaxoSmithKline

Research Triangle Park, NC 27709, US

BADIANG, Jennifer, G, c/o GlaxoSmithKline

Research Triangle Park, NC 27709, US

STEVENS, Kirk Lawrence, c/o GlaxoSmithKline

Research Triangle Park, NC 27709, US

VEAL, James Marvin, c/o GlaxoSmithKline

Research Triangle Park, NC 27709, US

TAVARES, Francis, Xavier

Research Triangle Park, NC 27709, US

DICKERSON, Scott Howard, GlaxoSmithKline

Research Triangle Park, NC 27709, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.